:quality(75)/cdn.jwplayer.com/v2/media/1F0cVlxK/poster.jpg?fit=%2C&ssl=1)
Updated on 02/09/2022 10:53 am The European Medicines Agency (EMA) on Tuesday began studying a request from Pfizer/BioNTech for the use of its booster doses in adolescents aged 12 to 15 years, which adds to another request that it was analyzing to authorize the third dose against COVID-19 in young people aged 16 and 17. […]
Tag: Pfizer
European Medicines Agency explains that the fourth dose in immunocompromised patients is their “first booster”
Updated on 02/03/2022 09:55 am The European Medicines Agency (EMA) has urged giving a fourth dose of Pfizer or Moderna to people with severely weakened immune systems, explaining that it is considered a “first reinforcement”. The head of Vaccination Strategy, Marco Cavaleryexplained that for people with a severely compromised immune system who have already received […]
USA: Pfizer can request license for anti-COVID vaccine for children under five
Updated on 02/01/2022 12:35 pm U.S. regulators have urged pharmaceutical company Pfizer to request emergency authorization for its two-dose COVID-19 vaccine for children between six months and five years of age, while it awaits the results of the three-injection treatment, The Associated Press reported. a source familiar with the matter. The company is expected to […]
Vaccinated with Sinovac receive strong boost with COVID injections from Pfizer, AstraZeneca or J&J, according to study
Updated on 01/24/2022 11:38 am A third booster dose with a COVID-19 vaccine produced by AstraZeneca, Pfizer-BioNTech, or Johnson & Johnson (J&J) significantly increases the antibody levels of those who previously received two doses of Sinovac’s CoronaVac injection, according to a study. The study revealed that CoronaVac received the greatest boost from a viral vector […]
EU regulator to decide on Pfizer’s COVID-19 pill at the end of January
The European Medicines Agency (EMA), the European Union’s (EU) medicines regulator, is scheduled to decide whether to approve Pfizer’s COVID-19 pill later this month, before conducting a final review of the drug. similar but less effective Merck in February, according to a source with knowledge of the matter. At the end of last year, the […]
New study shows that third dose of Pfizer increases antibodies against omicron
Updated on 01/18/2022 03:39 pm A new study evaluating the efficacy of Pfizer-BioNTech’s COVID-19 vaccine against the omicron variant indicates that three doses could offer “a sufficient level of protection” against the disease. The SARS-CoV-2 omicron (B.1.1.529) that circulates throughout the world is highly transmissible because it has accumulated a very high number, higher than […]
Everything you need to know about COVID vaccination for children 5 to 11 years old
:quality(75)/cdn.jwplayer.com/v2/media/OsYx5pLU/poster.jpg?fit=%2C&ssl=1)
The vaccination process against COVID-19 continues at a steady pace around the world, after governments began to immunize children under 12 years of age, and Peru is no exception. The Ministry of Health confirmed that the vaccines for this age group will arrive this Friday and the protection of minors against the coronavirus will begin […]
Pfizer Study Shows COVID-19 Booster Dose Can Be Administered With Pneumonia Vaccine
Updated on 01/12/2022 10:53 am Pfizer Inc announced that booster doses of its COVID-19 vaccine can be given along with its pneumonia vaccine and that they produced a strong safety and immune response in people 65 and older in a late-stage study. The study, started in May, tested the company’s next-generation pneumococcal conjugate vaccine, PREVNAR […]
Pfizer says new omicron vaccine will be ready in March
The US pharmaceutical Pfizer announced that it hopes to have a new vaccine against COVID-19 in March that improves protection against the omicron variant. The CEO of Pfizer, Albert Bourla, explained that it is not yet clear if this new product will be necessary, but said that his company is already beginning to manufacture the […]
To face omicron, a booster dose of Pfizer or Moderna is required, according to study
:quality(75)/cdn.jwplayer.com/v2/media/l4iFkiC9/poster.jpg?fit=%2C&ssl=1)
Updated on 01/07/2022 12:29 pm A study conducted by researchers at the Ragon Institute at Massachusetts General Hospital (United States) has confirmed that a booster dose of the COVID-19 vaccine from Moderna or Pfizer is needed to provide immunity against the omicron variant of SARS-CoV- two. The research results have been published in the journal […]